Cold autoimmune hemolytic anemia (cold AIHA) is a rare form of anemia in which antibodies called cold agglutinins attach to red blood cells in cooler parts of the body and mark them for destruction. It causes fatigue, jaundice, and blue or numb fingers in the cold, and it is diagnosed with a direct antiglobulin test and a cold agglutinin titer. Treatment centers on staying warm, treating any underlying cause, and, when needed, therapies that switch off antibody production or block complement.
Cold AIHA sits within the wider family of hematological disorders, and it behaves quite differently from the more common “warm” type. Below I walk through how it works, what patients notice, how we confirm it, and what management looks like in practice.
What Is Cold Autoimmune Hemolytic Anemia?
Hemolytic anemia means red blood cells are being destroyed faster than the bone marrow can replace them. Normal red cells live about 120 days; in active hemolysis that lifespan can shrink dramatically.
In the cold form, the culprit antibody is usually immunoglobulin M (IgM). It binds red cells best at temperatures below core body temperature, which is why the fingers, toes, ears, and nose, where blood cools as it circulates, are where trouble starts. Clinicians divide it into two broad groups:
- Primary cold agglutinin disease (CAD): a chronic condition, usually in older adults, driven by a small, low-grade clone of B cells in the bone marrow that produces the IgM antibody.
- Secondary cold agglutinin syndrome: triggered by another illness, such as Mycoplasma pneumoniae infection, Epstein-Barr virus (infectious mononucleosis), lymphomas and chronic lymphocytic leukemia, or, less often, autoimmune diseases like lupus.
Infection-related cases tend to be short-lived and settle within weeks as the infection clears. Primary CAD, by contrast, is a long-term condition with flares.
How Cold Agglutinins Destroy Red Cells
When blood cools in the extremities, IgM antibodies latch onto red cells and cause them to clump together (agglutination). IgM is very good at activating the classical complement pathway, a cascade of immune proteins that coat the cell surface.
As the blood rewarms, the IgM often falls off, but the complement fragment C3b stays behind. Macrophages in the liver recognize C3b-coated cells and remove them. This extravascular hemolysis is the main mechanism in most patients. When complement activation runs all the way to completion, red cells can also burst inside the blood vessels (intravascular hemolysis), releasing free hemoglobin that darkens the urine.
One practical term here is thermal amplitude: the highest temperature at which the antibody still binds. An antibody that stays active close to 30°C or above causes far more trouble than one that only works near refrigerator temperature, because peripheral skin routinely cools into that range.
Signs and Symptoms
Symptoms reflect both the anemia and the clumping of cells in cold skin. Many patients notice a clear seasonal pattern, feeling worse in winter or in heavily air-conditioned spaces.
- Fatigue, breathlessness, and pallor from a low hemoglobin.
- Jaundice (yellowing of skin and eyes) from increased bilirubin as hemoglobin is broken down.
- Dark or cola-colored urine during brisk episodes, from hemoglobin in the urine.
- Acrocyanosis: bluish, cold, sometimes painful fingers, toes, ears, or nose that improve on warming. This differs from classic Raynaud’s phenomenon, which shows sharp color changes (white, then blue, then red).
- Mild spleen enlargement in some patients, particularly when an underlying lymphoma is present.
Flares are often set off by cold exposure, infections, fever, surgery, or trauma, because each of these can boost complement activity.
How Doctors Diagnose Cold AIHA
Diagnosis combines evidence of hemolysis with proof that a cold-reacting antibody is responsible. A typical workup includes the tests in the table below.
| Test | What it shows in cold AIHA |
|---|---|
| Complete blood count (CBC) | Low hemoglobin; the MCV may read falsely high because clumped cells are counted as single large cells |
| Blood smear | Red cell agglutination (clumps) |
| Reticulocyte count | Raised, as the marrow tries to compensate |
| Bilirubin and LDH | Raised unconjugated bilirubin and LDH, markers of red cell breakdown |
| Haptoglobin | Low or undetectable, because it is used up binding free hemoglobin |
| Direct antiglobulin (Coombs) test | Strongly positive for complement (C3d); usually negative or weak for IgG |
| Cold agglutinin titer | Elevated, commonly 1:64 or higher at 4°C |
| Serum protein studies and bone marrow evaluation | May reveal a monoclonal IgM or an underlying B-cell clone or lymphoma |
Sample handling matters. Blood for the CBC and cold agglutinin testing should be kept at 37°C from the moment it is drawn; if it cools, the antibody drops off the cells in the lab and the result can be misleading. The differential diagnosis includes warm AIHA, drug-induced hemolysis, paroxysmal cold hemoglobinuria, and inherited red cell disorders.
Treatment and Day-to-Day Management
Management depends on how severe the anemia is and whether there is an underlying cause. For secondary cases, treating the infection or lymphoma is the foundation.
Staying warm
Cold avoidance is the first and most important step for everyone. That means dressing in layers, covering the head, hands, and feet, avoiding cold drinks and cold-water swimming, and warming the car before a winter drive. Our practical guide to cold-related anemia symptoms and treatment covers these routines in more detail. In hospital, any transfusions and intravenous fluids should be given through a blood warmer.
Medications
- Rituximab, an antibody that removes B cells, is a common first-line drug therapy when treatment is needed, sometimes combined with other agents such as bendamustine.
- Complement inhibitors interrupt the pathway that destroys the cells. Sutimlimab, which blocks the C1s component of the classical pathway, is approved in several countries for cold agglutinin disease.
- Corticosteroids, a mainstay in warm AIHA, generally work poorly in primary cold agglutinin disease and are not relied on long term.
- Folic acid supplementation supports the increased red cell production of chronic hemolysis.
In a severe acute crisis, plasma exchange can quickly lower the antibody level as a temporary bridge. Removing the spleen is rarely helpful, because the liver, not the spleen, clears most complement-coated cells.
When to See a Doctor
Seek prompt medical review if you notice new yellowing of the eyes, dark urine, unusual breathlessness, or fingers and toes that turn blue in the cold. Go to emergency care for chest pain, fainting, or rapidly worsening weakness, which can signal a steep drop in hemoglobin.
If you already have a diagnosis, let your team know before any surgery, especially procedures involving cooling, so the operating theatre and fluids can be kept warm. For a wider view of how red cell disorders fit together, see our guide to hematology and blood health and the anemia hub.
Frequently Asked Questions
Is cold autoimmune hemolytic anemia the same as cold agglutinin disease?
Cold agglutinin disease is the primary, chronic form of cold AIHA driven by a B-cell clone. Cold AIHA is the broader term, which also includes temporary cases triggered by infections or other illnesses.
Can cold AIHA go away on its own?
Cases triggered by Mycoplasma or Epstein-Barr virus usually resolve within weeks as the infection clears. Primary cold agglutinin disease is typically lifelong, though many people have mild disease controlled by keeping warm.
Why don’t steroids work well for cold AIHA?
Steroids mainly dampen the IgG-driven, spleen-based destruction seen in warm AIHA. In cold AIHA the damage is driven by IgM and complement with clearance in the liver, so steroids have little effect on the main mechanism.
Is it safe to travel to cold places with this condition?
Many patients travel successfully with careful planning: thermal clothing, gloves, heated accommodation, and avoiding prolonged outdoor exposure. Discuss trips with your hematologist first, particularly if your hemoglobin is low or you have had recent flares.
